AIMP1 and familial pancreatic carcinoma: A number of studies have shown that EMAP-II is a tumor suppressor, for example, in fibrosarcoma (Haridas et al., 2008), pituitary adenomas (Bottoni et al., 2007), pancreatic cancer (Awasthi et al., 2010, 2011, 2013), gliomas (Liu et al., 2015).